Ex-FDA Chief Says J&J Knew Adolescent Risperdal Risks
Ex-Food and Drug Administration commissioner David Kessler told a Philadelphia jury on Wednesday that a Johnson & Johnson unit had information linking the blockbuster antipsychotic drug Risperdal to incidences of breast...To view the full article, register now.
Already a subscriber? Click here to view full article